Objective To retrospectively compare image quality of a lowered dose CT protocol to a standard CT protocol in children with suspicion of craniosynostosis. Methods Forty-eight patients (age 0- 35 months), who presented with a cranial deformity underwent cranial 3D CT to assess sutural patency: between 2009 – 2010, 24 patients were imaged with a standard protocol (CTDIvol 32.18 mGy), from 2011-2012, 24 underwent a low dose protocol (0.94 mGy) combined with iterative reconstruction. Image quality was evaluated by both expert reading and objective analysis. Differences were assessed by independent t-test and Mann-Whitney U test, interreader agreement by Cohen's Kappa test. Results Effective dose of the low dose protocol was 0.08 mSv, corresponding to a reduction of 97 %. Image quality was similar in both groups in terms of overall diagnostic acceptability, objective noise measurements, subjective cranial bone edge sharpness and presence of artefacts. For objective sharpness of cranial bone-brain interface and subjective perception of noise, the images of the low dose protocol were superior. For all evaluated structures, interreader agreement was moderate to almost perfect. Conclusion In the diagnosis of craniosynostosis in children with cranial deformities, a dedicated sub 0.1 mSv cranial 3DCT protocol can be used without loss in image quality. Key Points • 3DCT is used for the diagnosis of craniosynostosis. • Imaging protocols should be optimized to minimize radiation exposure to children. • Combining 80 kVp with iterative reconstruction can help to reduce dose. • A sub 0.1 mSv cranial 3DCT protocol can be used without loss of diagnostic quality.
Background: Approximately one-third of men having undergone gonadotoxic treatment in their childhood experience impaired testicular function for whom autologous transplantation of cryopreserved immature testicular tissue may represent the only opportunity to restore their fertility. Pre-clinical studies have demonstrated successful restoration of spermatogenesis following grafting of immature testicular tissue in various species, including non-human primates. In 2002, our institution pioneered with clinical testicular tissue banking for fertility preservation in boys and adolescents. Over time, this strategy has been increasingly implemented by numerous fertility centres worldwide for patients at high risk of treatment-induced sterility. Here, we report the first human case of autologous transplantation of frozen-thawed immature testicular tissue. Patient: In 2008, testicular tissue was cryopreserved from a pre-pubertal boy diagnosed with sickle cell disease. The procedure was performed after a three-year hydroxyurea treatment and prior to receiving conditioning therapy with busulfan and cyclophosphamide for haematopoietic stem cell transplantation. One testis was surgically removed, sectioned into small fragments, and cryopreserved. Histological analysis confirmed preserved tubular architecture and the presence of spermatogonia. During the period from 2022 to 2024, the patient consistently presented with azoospermia. In December 2024, at the time of transplantation, two abnormal sperm cells were detected after enzymatic digestion. Method: Eleven testicular tissue fragments (4–21 mm 3 ) were thawed and autologously grafted to four intra-testicular and four subcutaneous scrotal sites. Over a one-year follow-up period, graft survival, vascularization, hormone profiles, and semen parameters were monitored. One year after transplantation, all grafts were surgically retrieved. Results: Post-operative recovery was uneventful. No significant changes in endocrine or semen parameters were observed during follow-up. Whereas the intra-testicular grafts exhibited a compact parenchyma that was distinct from the looser surrounding adult parenchyma and remained readily identifiable as graft tissue, the scrotal grafts appeared more fibrotic. Enzymatic digestion of the grafts was required to recover spermatozoa, with one spermatozoon obtained from one of the four intra-testicular grafts. Histological evaluation revealed intact tubular architecture and maturation of somatic cells across all grafts. Spermatogonial stem cells, together with evidence of active spermatogenesis, were identified in two of the four intra-testicular grafts, whereas no germ cells were detected in the subcutaneous scrotal grafts. Conclusion: These findings demonstrate that human immature testicular tissue can survive long-term cryostorage, revascularize after transplantation and establish spermatogenesis in vivo . This study provides essential proof-of-concept for fertility restoration in individuals who banked testicular tissue before puberty. Funding: This study was supported by the Research Programme of FWO Vlaanderen (Research Foundation-Flanders; G0A6U25N) and VUB strategic research program (SRP89). Trial Registration: NCT05414045
Paediatric gonadotoxic treatments can compromise male fertility, yet prospective data systematically tracking pubertal development are scarce. Immature testicular tissue banking (TTB) has been introduced as an experimental fertility preservation option for (pre-)pubertal boys, but its long-term safety and interaction with gonadotoxic treatment are not fully understood. This single-centre prospective cohort study systematically followed 23 boys, treated for malignant or non-malignant conditions, between 2017 and 2025 [median 4.0 (0.1–6.9) years], including 15 who underwent TTB. Unlike previous studies, this research combined repeated assessments of pubertal staging, testicular volumes, parenchymal integrity, reproductive hormones, and bone age and density, enabling a multidimensional evaluation of pubertal development. Gonadotoxic treatments, particularly myeloablative conditioning, were associated with reduced post-pubertal testicular volumes and altered hormone profiles, including elevated luteinising hormone and follicle-stimulating hormone, and reduced inhibin B, while anti-Müllerian hormone remained largely stable. Puberty occurred spontaneously and testosterone production was preserved in all patients. The testicular parenchyma appeared unaffected by the biopsy, and although some biopsied testes showed lower volumes, similar reductions could be observed in non-biopsied testes. These results support the safety of TTB, with no evident adverse effects on testicular structure or function; however, larger multicentric prospective studies are needed to confirm these findings.
2 January 2023 in Journal of the Belgian Society of Radiology
Teaching point: Myopericytoma is a rare soft tissue tumor but should be considered in the differential diagnosis of infants with a fast-growing perivascular tumor.